MedPath

Marstacimab

Generic Name
Marstacimab
Brand Names
-
Drug Type
Biotech
Chemical Formula
-
CAS Number
1985638-39-8
Unique Ingredient Identifier
0UB3OA67O7
Background

Marstacimab is a human Monoclonal Antibody Directed Against Tissue Factor Pathway Inhibitor currently being developed by Pfizer for the treatment of hemophilia A and hemophilia B.

Associated Conditions
-
Associated Therapies
-
© Copyright 2025. All Rights Reserved by MedPath